and chiral isocyanides do not have a great influence on the
1
1
stereoselectivity of the reaction. Furthermore, a negligible
stereoselectivity was observed when chiral carboxylic acids
1
2
were used. Additionally, using 1,8-naphthalaldehydic
acid, 2-formylphenoxyacetic acid, and 2-formylphenoxy-2-
benzoic acid as bifunctional reagents in Ugi condensations,
a series of rare six-, seven-, and eight-membered heterocyclic
13
rings was obtained. In all cases, the compounds were
isolated in low yield and racemic form and with poor
diastereoselectivity. The steric biases imposed by a cyclic
transition state can, however, facilitate the achievement of
good diastereoselectivity in intramolecular Ugi reactions.
As such, a diastereomeric ratio of 9:1 was observed by a
Figure 1. Conformationally constrained amino acid scaffolds
Aba 1a, Aia 1b/2, and Ata 1c.
14
reaction using an N-protected 2-formyltryptophan reagent 3
1
,4 long-range asymmetric induction for the formation of
22
that was previously developed by us (see the Supporting
Information for more details). The preparation of racemic
14c
2,5-substituted tetrahydrobenzoxazepines.
Seven-membered N-heterocycles, including pyrrolo-
5- or 7-carboxamidoindolobenzazepinones was reported by
application of an intramolecular Ugi-3CR.
and indoloazepinones, are very interesting in medicinal
chemistry, where they represent an important class of
23
In this paper, we report the development of a new
stereoselective Ugi-3CR that allows the synthesis of
novel, optically pure 1-carbamoyl-Aia heterocycles by
condensation of 2-formyl-L-Trp 3 with different amines
and isocyanides. In order to find the best reaction condi-
tions for the synthesis of the prototype Aia derivatives,
Boc-2-formyl-L-tryptophan 3, 4-methoxy-benzylamine
1
5
“
privileged scaffolds”. Previously, we have suggested
that the 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one
a (Aba), 4-aminoindoloazepinone 1b (Aia), and 4-ami-
1
1
6
notriazolodiazepinone 1c (Ata) (Figure 1) might also
serve as privileged templates since these scaffolds were
used to obtain a variety of peptide and peptidomimetic
ligands for several G protein-coupled receptors. Examples
5
d, and tert-butyl isocyanide 4c were chosen as model
1
7
18
include opioid GPCRs, neurokinin 1, and somatostatin
substrates to optimize the reaction conditions (Table 1).
Because we recently investigated microwave-assisted,
19
receptors. 1-Substituted analogues such as 2 (Figure 1),
having three points of diversification, are therefore interest-
ing in medicinal chemistry.
2
4
solvent- and catalyst-free conversions, the development
of such conditions was of particular interest.
Only the 1-phenyl-substituted analogues of 1a have
In a first step, we optimized the microwave irradiation
parameters. Initially, under solvent-free microwave
2
been reported. As a continuation of our studies on
0
2
1
isocyanide-based multicomponent reactions, we proposed
that the 1-carboxamido-substituted Aia scaffold 2 (R =
2
4b
conditions,
the reaction did not proceed when the
3
mixture was heated at 100 °C for 3 min (entry 1, Table 1).
In addition, performing the reaction in MeOH (0.1 M)
under microwave conditions and increasing the tempera-
ture to 80 °C for 2 h did not lead to the desired Ugi
product (entries 2 and 3, Table 1). To our delight, the
desired product was, however, observed upon further
increase of the temperature (entries 4À9, Table 1). Suc-
cessive temperature increase from 80 to 175 °C and
applying a reaction time of 1 h 30 to 2 h afforded total
conversion to 6f (75% yield, 44/56 dr, entry 8, Table 1).
CO-NHR ) could be synthesized via the intramolecular Ugi
3
(
12) (a) Yamada, T.; Motoyama, N.; Taniguchi, T.; Kazuta, Y.;
Miyazawa, T.; Matsumoto, K.; Sugiura, M. Chem. Lett. 1987, 723. (b)
Golebioski, A.; Klopfenstein, S. R.; Shao, X.; Chen, J. J.; Colson, A. O.;
Grieb, A. L.; Russel, A. F. Org. Lett. 2000, 2, 2615.
(
13) (a) Ley, S. V.; Taylor, S. J. Bioorg. Med. Chem. Lett. 2002, 12,
813. (b) Harriman, G. C. B. Tetrahedron Lett. 1997, 38, 5591.
14) (a) Basso, A.; Banfi, L.; Riva, R. Eur. J. Org. Chem. 2010, 1831.
b) van Berkel, S. S.; B o€ gels, B. G. M.; Wijdeven, M. A.; Westermann,
1
(
(
B.; Rutjes, F. P. J. T. Eur. J. Org. Chem. 2012, 3543. (c) Banfi, L.; Bagno,
A.; Basso, A.; De Stanis, C.; Riva, R.; Rastrelli, F. Eur. J. Org. Chem.
2013, 5064.
1
Two diastereomers were observed by HPLC and H
(
15) Evans, B. E.; Rittle, K. E.; Bock, M. G.; DiPardo, R. M.;
Freidinger, R. M.; Whitter, W. L.; Lundell, G. F.; Veber, D. F.;
Anderson, P. S.; Chang, R. S. L.; Lotti, V. J.; Cerino, D. J.; Chen,
T. B.; Kling, P. J.; Kunkel, K. A.; Springer, J. P.; Hirshfield, J. J. Med.
Chem. 1988, 3, 2235.
NMR, and these could be separated by silica gel column
chromatography (see the Supporting Information). No
reaction occurred at room temperature in methanol with
reaction times of up to 48 h (entry 10, Table 1). Because of
a lack in stereoselectivity, we turned our attention to
exploring lower temperatures and prolonged reaction
(
16) Buysse, K.; Farad, J.; Nikolaou, A.; Vanderheyden, P.; Vau-
quelin, G.; Sejer Pedersen, D.; Tourw ꢀe , D.; Ballet, S. Org. Lett. 2011, 13,
468.
17) Novoa, A.; Van Drope, S.; Wynendaele, E.; Spetea, M.; Bracke,
6
(
N.; Stalmans, S.; Betti, C.; Chung, N. N.; Lemieux, C.; Zuegg, J.;
Cooper, M. A.; Tourw ꢀe , D.; De Spiegeleer, B.; Schiller, P. W.; Ballet,
S. J. Med. Chem. 2012, 55, 9549.
(18) Ballet, S.; Feytens, D.; Buysse.; Chang, N. C.; Lemieux, C.;
Tumati, S.; Keresztes, A.; Van Duppen, J.; Lai, J.; Varga, E.; Porreca,
(22) Pulka, K.; Feytens, D.; Van den Eynde, I.; De Wachter, R.;
Kosson, P.; Misicka, A.; Lipkowski, A.; Chung, N. N.; Schiller, P. W.;
Tourw ꢀe , D. Tetrahedron 2007, 63, 1459.
(23) Beaumont, S.; Retailleau, P.; Dauban, P.; Dodd, R. H. Eur. J.
Org. Chem. 2008, 5162.
(24) For selected examples, see: (a) Jida, M.; Deprez-Poulain, R.;
Malaquin, S.; Roussel, P.; Agboussou-Niedercorn, F.; Deprez, B.;
Laconde, G. Green Chem. 2010, 12, 961. (b) Jida, M.; Malaquin, S.;
Deprez-Poulain, R.; Laconde, G.; Deprez, B. Tetrahedron Lett. 2010, 51,
5109. (c) Jida, M.; Soueidan, O. M.; Deprez, B.; Laconde, G.;
Deprez-Poulain, R. Green Chem. 2012, 14, 909.
F.; Schiller, P. W.; Vanden Broeck, J.; Tourw ꢀe , D. J. Med. Chem. 2011,
5
4, 2467.
19) Feytens, D.; De Vlaeminck, M.; Cescato, R.; Tourw ꢀe , D.; Reubi,
J. C. J. Med. Chem. 2009, 52, 95.
20) Ballet, S.; Urbanczyk-Lipkowska, Z.; Tourw ꢀe , D. Synlett 2005,
8, 2791.
21) Malaquin, S.; Jida, M.; Gesquiere, J.-C.; Deprez-Poulain, R.;
(
(
1
(
Deprez, B.; Laconde, G. Tetrahedron Lett. 2010, 51, 2983.
Org. Lett., Vol. 15, No. 22, 2013
5867